Biosignatures are currently working with our clinical partners in the following areas:

• Urology - In this study Biosignatures has discovered and refined three diagnostic signatures for renal, prostate and bladder cancer. The signatures were created using Biosignatures’ unique Tiger technology.
  
  
• Endocrinology - In this study, due to start in early 2011, Biosignatures are hoping to discover a signature that will predict the presence of thyroid cancer.

The company is getting ready to start on projects in breast cancer, ovarian cancer and neurodegenerative AD/PD.

Biosignatures are actively looking for more clinical collaborators. If you have a diagnostic need which you think we may be able to help with, please do contact us.